Regarding immune indices, serum IgA, IgM, and IgG levels in the OMS group were significantly higher than those in the Control (p < 0.05), indicating a marked enhancement of humoral immunity. The gene discussed is CD40LG; the disease is opsoclonus-myoclonus syndrome.